OCTOVA: A trial of olaparib and cediranib in recurrent ovarian cancer
This trial is looking to find better treatments for women with ovarian cancer that has come back. The trial is looking to find out if the drugs olaparib and cediranib are safe and work better than the standard chemotherapy drug paclitaxel. The drugs involved in this trial are: Paclitaxel – the known drug. This is a chemotherapy drug given …